<?xml version="1.0" encoding="UTF-8"?>
<gtr:projectOverview xmlns:gtr="http://gtr.ukri.org/api"><gtr:projectComposition><gtr:collaborations><gtr:collaborator url="http://gtr.ukri.org:80/organisation/75E77BF3-29B4-4699-9CD9-223230E8A463"><gtr:id>75E77BF3-29B4-4699-9CD9-223230E8A463</gtr:id><gtr:name>Babraham Institute</gtr:name></gtr:collaborator><gtr:collaborator url="http://gtr.ukri.org:80/organisation/FD097AE8-7743-4F06-823B-ABFDF6A74F4E"><gtr:id>FD097AE8-7743-4F06-823B-ABFDF6A74F4E</gtr:id><gtr:name>University of Arkansas</gtr:name><gtr:address><gtr:line1>Phoenix House</gtr:line1><gtr:line2>348 Arkansas Avenue</gtr:line2><gtr:region>outside UK</gtr:region></gtr:address></gtr:collaborator><gtr:collaborator url="http://gtr.ukri.org:80/organisation/D1774113-D5D2-4B7C-A412-66A90FE4B96F"><gtr:id>D1774113-D5D2-4B7C-A412-66A90FE4B96F</gtr:id><gtr:name>University of Cambridge</gtr:name><gtr:address><gtr:line1>Lensfield Road</gtr:line1><gtr:line4>Cambridge</gtr:line4><gtr:postCode>CB2 1EW</gtr:postCode><gtr:region>East of England</gtr:region><gtr:country>United Kingdom</gtr:country></gtr:address></gtr:collaborator><gtr:collaborator url="http://gtr.ukri.org:80/organisation/818CD6C9-61EE-41F2-9F37-0C7A8F43E25D"><gtr:id>818CD6C9-61EE-41F2-9F37-0C7A8F43E25D</gtr:id><gtr:name>University of Birmingham</gtr:name><gtr:address><gtr:line1>Edgbaston Park Road</gtr:line1><gtr:line2>Edgbaston</gtr:line2><gtr:postCode>B15 2TT</gtr:postCode><gtr:region>West Midlands</gtr:region><gtr:country>United Kingdom</gtr:country></gtr:address></gtr:collaborator><gtr:collaborator url="http://gtr.ukri.org:80/organisation/68D0E3C9-9246-4CFC-B5E9-48584CF82993"><gtr:id>68D0E3C9-9246-4CFC-B5E9-48584CF82993</gtr:id><gtr:name>University of Manchester</gtr:name><gtr:address><gtr:line1>Oxford Road</gtr:line1><gtr:city>Manchester</gtr:city><gtr:postCode>M13 9PL</gtr:postCode><gtr:region>North West</gtr:region><gtr:country>United Kingdom</gtr:country></gtr:address></gtr:collaborator></gtr:collaborations><gtr:leadResearchOrganisation url="http://gtr.ukri.org:80/organisation/D1774113-D5D2-4B7C-A412-66A90FE4B96F"><gtr:id>D1774113-D5D2-4B7C-A412-66A90FE4B96F</gtr:id><gtr:name>University of Cambridge</gtr:name><gtr:department>Biochemistry</gtr:department><gtr:address><gtr:line1>Lensfield Road</gtr:line1><gtr:line4>Cambridge</gtr:line4><gtr:postCode>CB2 1EW</gtr:postCode><gtr:region>East of England</gtr:region><gtr:country>United Kingdom</gtr:country></gtr:address><gtr:typeInd>RO</gtr:typeInd></gtr:leadResearchOrganisation><gtr:organisationRoles><gtr:organisationRole url="http://gtr.ukri.org:80/organisation/D1774113-D5D2-4B7C-A412-66A90FE4B96F"><gtr:id>D1774113-D5D2-4B7C-A412-66A90FE4B96F</gtr:id><gtr:name>University of Cambridge</gtr:name><gtr:address><gtr:line1>Lensfield Road</gtr:line1><gtr:line4>Cambridge</gtr:line4><gtr:postCode>CB2 1EW</gtr:postCode><gtr:region>East of England</gtr:region><gtr:country>United Kingdom</gtr:country></gtr:address><gtr:roles><gtr:role><gtr:name>COLLABORATOR</gtr:name></gtr:role><gtr:role><gtr:name>LEAD_RO</gtr:name></gtr:role></gtr:roles></gtr:organisationRole><gtr:organisationRole url="http://gtr.ukri.org:80/organisation/75E77BF3-29B4-4699-9CD9-223230E8A463"><gtr:id>75E77BF3-29B4-4699-9CD9-223230E8A463</gtr:id><gtr:name>Babraham Institute</gtr:name><gtr:roles><gtr:role><gtr:name>COLLABORATOR</gtr:name></gtr:role></gtr:roles></gtr:organisationRole><gtr:organisationRole url="http://gtr.ukri.org:80/organisation/FD097AE8-7743-4F06-823B-ABFDF6A74F4E"><gtr:id>FD097AE8-7743-4F06-823B-ABFDF6A74F4E</gtr:id><gtr:name>University of Arkansas</gtr:name><gtr:address><gtr:line1>Phoenix House</gtr:line1><gtr:line2>348 Arkansas Avenue</gtr:line2><gtr:region>outside UK</gtr:region></gtr:address><gtr:roles><gtr:role><gtr:name>COLLABORATOR</gtr:name></gtr:role></gtr:roles></gtr:organisationRole><gtr:organisationRole url="http://gtr.ukri.org:80/organisation/818CD6C9-61EE-41F2-9F37-0C7A8F43E25D"><gtr:id>818CD6C9-61EE-41F2-9F37-0C7A8F43E25D</gtr:id><gtr:name>University of Birmingham</gtr:name><gtr:address><gtr:line1>Edgbaston Park Road</gtr:line1><gtr:line2>Edgbaston</gtr:line2><gtr:postCode>B15 2TT</gtr:postCode><gtr:region>West Midlands</gtr:region><gtr:country>United Kingdom</gtr:country></gtr:address><gtr:roles><gtr:role><gtr:name>COLLABORATOR</gtr:name></gtr:role></gtr:roles></gtr:organisationRole><gtr:organisationRole url="http://gtr.ukri.org:80/organisation/68D0E3C9-9246-4CFC-B5E9-48584CF82993"><gtr:id>68D0E3C9-9246-4CFC-B5E9-48584CF82993</gtr:id><gtr:name>University of Manchester</gtr:name><gtr:address><gtr:line1>Oxford Road</gtr:line1><gtr:city>Manchester</gtr:city><gtr:postCode>M13 9PL</gtr:postCode><gtr:region>North West</gtr:region><gtr:country>United Kingdom</gtr:country></gtr:address><gtr:roles><gtr:role><gtr:name>COLLABORATOR</gtr:name></gtr:role></gtr:roles></gtr:organisationRole></gtr:organisationRoles><gtr:personRoles><gtr:personRole url="http://gtr.ukri.org:80/person/AA85AE6A-D3AA-426F-A3E8-06C8403421A4"><gtr:id>AA85AE6A-D3AA-426F-A3E8-06C8403421A4</gtr:id><gtr:firstName>Richard</gtr:firstName><gtr:otherNames>William</gtr:otherNames><gtr:surname>Farndale</gtr:surname><gtr:roles><gtr:role><gtr:name>CO_INVESTIGATOR</gtr:name></gtr:role></gtr:roles></gtr:personRole><gtr:personRole url="http://gtr.ukri.org:80/person/36D32D69-E062-4C15-811F-152F1DAF7155"><gtr:id>36D32D69-E062-4C15-811F-152F1DAF7155</gtr:id><gtr:firstName>Gavin</gtr:firstName><gtr:otherNames>Edward</gtr:otherNames><gtr:surname>Jarvis</gtr:surname><gtr:roles><gtr:role><gtr:name>PRINCIPAL_INVESTIGATOR</gtr:name></gtr:role></gtr:roles></gtr:personRole></gtr:personRoles><gtr:project url="http://gtr.ukri.org:80/projects?ref=G0601378"><gtr:id>3A46A59C-ABDE-429F-8B4B-6521AB27B87A</gtr:id><gtr:title>Interaction of platelet receptors with native collagen sequences and their downstream signalling effects</gtr:title><gtr:status>Closed</gtr:status><gtr:grantCategory>Research Grant</gtr:grantCategory><gtr:grantReference>G0601378</gtr:grantReference><gtr:abstractText>Platelets are small cells found in the blood throughout the whole body. Normally, platelets do nothing and stay in a resting state for about ten days after which they die and are replaced. However, when a blood vessel is damaged, the platelets become active and respond immediately like an emergency service. They stick to the injured vessel and form a clot which prevents loss of blood and begins the process of healing. Unfortunately though, there are times when platelets block blood vessels in a manner which is harmful to the person. Over time, coronary arteries, which supply blood to the heart, can become obstructed with deposits of fat and cholesterol. These fatty deposits are more brittle than the elastic arteries and sometimes crack under stress. When this happens the platelets stick to the damaged area and can completely block the artery causing a heart attack. In both the damaged vessel and the cracked coronary artery, the platelets stick to a protein in the tissue called collagen. Collagen is very strong and acts like a soft tissue skeleton holding all the various body parts together. When platelets stick to collagen they become active and then stick to each other as well. 

Our research looks at the way collagen sticks to and activates platelets. We already know that collagen sticks to particular proteins that are found on the surface of the platelet. Two of the most important of these proteins are called GPVI and ??2?O1. GPVI and ??2?O1 only stick to particular areas of the collagen. To find these areas we have made a series of 57 mini-collagens which resemble small segments of natural collagen found in our blood vessels. We now know that platelets only stick to a small number of these mini-collagens. This enables us to focus on the detailed properties of the collagen which makes it stick to the platelet. 

Designing new treatments is a complex process and requires a detailed understanding of the processes which we want to influence. Our research attempts to provide that understanding which may assist in the design of new medicines to treat heart disease. Although the process of research is time-consuming, the advantage of looking in detail is that we often discover new things which we were not expecting to see, which, in the long run, gives us even more options for treating real people with heart disease, which is our ultimate goal.</gtr:abstractText><gtr:technicalSummary>GPVI and alpha2beta1 are major collagen receptors on platelets which interact at different locations on the collagen molecule. GPVI binds to GPO motifs and alpha2beta1 to motifs containing GER. We have synthesized 57 peptides representing the full triple-helical portion of collagen III. Murine platelets bind efficiently to peptides III-04 and III-30 from this Toolkit. Binding to III-04 is dependent on GPVI and alpha2beta1, but binding to III-30 is only dependent on GPVI. We propose that the binding of platelets to III-04 involves the formation of a GPVI/alpha2beta1 receptor complex with previously unrecognised signalling consequences. We aim to confirm the formation of this complex, and characterise the signalling that results. Peptide III-30 represents a native GPVI binding sequence in collagen. We will identify which residues, in addition to the GPOs, contribute to the GPVI binding motif and how they interact with the binding site of GPVI.</gtr:technicalSummary><gtr:fund><gtr:end>2010-06-30</gtr:end><gtr:funder url="http://gtr.ukri.org:80/organisation/C008C651-F5B0-4859-A334-5F574AB6B57C"><gtr:id>C008C651-F5B0-4859-A334-5F574AB6B57C</gtr:id><gtr:name>MRC</gtr:name></gtr:funder><gtr:start>2007-07-01</gtr:start><gtr:type>INCOME_ACTUAL</gtr:type><gtr:valuePounds>319888</gtr:valuePounds></gtr:fund><gtr:output><gtr:artisticAndCreativeProductOutputs/><gtr:collaborationOutputs><gtr:collaborationOutput><gtr:collaboratingOrganisation>University of Cambridge</gtr:collaboratingOrganisation><gtr:country>United Kingdom of Great Britain &amp; Northern Ireland (UK)</gtr:country><gtr:department>Department of Pathology</gtr:department><gtr:description>Pathology, Cambridge</gtr:description><gtr:id>ABE16C94-BAFF-4EAA-9C87-B219EF5C254C</gtr:id><gtr:impact>Collaboration is ongoing. A paper was presented at the XXII ISTH in Boston in 2009.</gtr:impact><gtr:outcomeId>B57533A5765-1</gtr:outcomeId><gtr:partnerContribution>Supply of genetically-modified mice Use of flow cytometer</gtr:partnerContribution><gtr:piContribution>Supply of peptides and expertise in their use and experimental design.</gtr:piContribution><gtr:sector>Academic/University</gtr:sector><gtr:start>2007-01-01</gtr:start></gtr:collaborationOutput><gtr:collaborationOutput><gtr:collaboratingOrganisation>Babraham Institute</gtr:collaboratingOrganisation><gtr:country>United Kingdom of Great Britain &amp; Northern Ireland (UK)</gtr:country><gtr:description>Babraham Institute, FcRgamma</gtr:description><gtr:id>8A1EFECD-E511-4C6A-82D1-50135FACC48E</gtr:id><gtr:impact>Publication: 18755982 Collaboration ongoing in other projects using our GM mice</gtr:impact><gtr:outcomeId>9FA98B4CD75-1</gtr:outcomeId><gtr:piContribution>Supply of genetically modified mice</gtr:piContribution><gtr:sector>Private</gtr:sector><gtr:start>2007-01-01</gtr:start></gtr:collaborationOutput><gtr:collaborationOutput><gtr:collaboratingOrganisation>University of Arkansas</gtr:collaboratingOrganisation><gtr:country>United States of America</gtr:country><gtr:department>University of Arkansas for Medical Sciences</gtr:department><gtr:description>Little Rock, GpVI-/-</gtr:description><gtr:id>F9D9695E-D503-4384-ABDF-B719E24E85A4</gtr:id><gtr:impact>Publication: 18339097 Data from GM mice in Little Rock has not yet been published.</gtr:impact><gtr:outcomeId>87BD7FC4F54-1</gtr:outcomeId><gtr:partnerContribution>Provision of genetically-modified mice</gtr:partnerContribution><gtr:piContribution>Training in and conducting adhesion assays.</gtr:piContribution><gtr:sector>Academic/University</gtr:sector><gtr:start>2007-01-01</gtr:start></gtr:collaborationOutput><gtr:collaborationOutput><gtr:collaboratingOrganisation>University of Birmingham</gtr:collaboratingOrganisation><gtr:country>United Kingdom of Great Britain &amp; Northern Ireland (UK)</gtr:country><gtr:department>College of Life and Environmental Sciences</gtr:department><gtr:description>Birmingham, UK</gtr:description><gtr:id>3D75EB17-5B68-4876-B965-5286366FEEF4</gtr:id><gtr:impact>Collaborators in Birmingham have carried out intracellular signalling work to contribute to an ongoing study.</gtr:impact><gtr:outcomeId>Wpv9sWhNFzV-1</gtr:outcomeId><gtr:partnerContribution>Collaborative work on a study investigating the role of ADAP in platelet function. Scientists in Birmingham have processed samples prepared in Cambridge.</gtr:partnerContribution><gtr:piContribution>Signalling work carried out on ADAP project</gtr:piContribution><gtr:sector>Academic/University</gtr:sector><gtr:start>2009-01-01</gtr:start></gtr:collaborationOutput><gtr:collaborationOutput><gtr:collaboratingOrganisation>University of Manchester</gtr:collaboratingOrganisation><gtr:country>United Kingdom of Great Britain &amp; Northern Ireland (UK)</gtr:country><gtr:department>Faculty of Life Sciences</gtr:department><gtr:description>Manchester, III-30 crystals</gtr:description><gtr:id>BCF3CAA8-629B-4D1C-A43E-3FCC8C114FC8</gtr:id><gtr:impact>To date, crystals have been obtained as well as preliminary diffraction data. The structural work is ongoing.</gtr:impact><gtr:outcomeId>514FCE0F2E0-1</gtr:outcomeId><gtr:partnerContribution>Collaborators carry out crystallisation and structural studies on triple-helical peptides</gtr:partnerContribution><gtr:piContribution>Our laboratory supplies the peptides designed for crystallisation</gtr:piContribution><gtr:sector>Academic/University</gtr:sector><gtr:start>2007-01-01</gtr:start></gtr:collaborationOutput></gtr:collaborationOutputs><gtr:disseminationOutputs/><gtr:exploitationOutputs/><gtr:furtherFundingOutputs/><gtr:impactSummaryOutputs/><gtr:intellectualPropertyOutputs/><gtr:otherResearchOutputs/><gtr:policyInfluenceOutputs/><gtr:productOutputs/><gtr:researchDatabaseAndModelOutputs/><gtr:researchMaterialOutputs><gtr:researchMaterialOutput><gtr:description>Triple-helical GpVI-binding peptide derived from a native human collagen sequence</gtr:description><gtr:id>278D312E-D18D-48E4-ADAF-B0AA4B5282E7</gtr:id><gtr:impact>Characterisation of the interaction between LAIR and collagen. Currently generating crystal structure for the peptide in collaboration.</gtr:impact><gtr:outcomeId>C3476850D0F</gtr:outcomeId><gtr:providedToOthers>true</gtr:providedToOthers><gtr:title>GpVI binding peptide</gtr:title><gtr:type>Technology assay or reagent</gtr:type><gtr:yearFirstProvided>2007</gtr:yearFirstProvided></gtr:researchMaterialOutput></gtr:researchMaterialOutputs><gtr:softwareAndTechnicalProductOutputs/><gtr:spinOutOutputs/></gtr:output><gtr:publications><gtr:publication><gtr:id>A4F91BEB-5CF1-42DD-B469-8C01B9F07626</gtr:id><gtr:title>The impact of factor Xa inhibition on axial dependent arterial thrombus formation triggered by a tissue factor rich surface.</gtr:title><gtr:parentPublicationTitle>Journal of thrombosis and thrombolysis</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/f40bc21122a09f7f86f118a55aedbfbf"><gtr:id>f40bc21122a09f7f86f118a55aedbfbf</gtr:id><gtr:otherNames>Pugh N</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2012-01-01</gtr:date><gtr:issn>0929-5305</gtr:issn><gtr:outcomeId>pm_15248_28_22120925</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>097ADDDA-DA4F-4322-9986-E2EB6CF16C98</gtr:id><gtr:title>Structure-based mutational analysis of eIF4E in relation to sbm1 resistance to pea seed-borne mosaic virus in pea.</gtr:title><gtr:parentPublicationTitle>PloS one</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/c57b4d890bed4d0d44cb3218ad0b00b1"><gtr:id>c57b4d890bed4d0d44cb3218ad0b00b1</gtr:id><gtr:otherNames>Ashby JA</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2011-01-01</gtr:date><gtr:issn>1932-6203</gtr:issn><gtr:outcomeId>Jn5LqW4VV97</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>0FC6958A-9C3F-4AF6-9987-672B420BBA91</gtr:id><gtr:title>The properties conferred upon triple-helical collagen-mimetic peptides by the presence of cysteine residues.</gtr:title><gtr:parentPublicationTitle>Peptides</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/b2bf6ecdd71b9c2a69085ff563c22d5d"><gtr:id>b2bf6ecdd71b9c2a69085ff563c22d5d</gtr:id><gtr:otherNames>Slatter DA</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2012-01-01</gtr:date><gtr:issn>0196-9781</gtr:issn><gtr:outcomeId>pm_15248_28_22555281</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>F6B23525-822F-45AF-B64D-63899FC62393</gtr:id><gtr:title>A golden approach to ion channel inhibition.</gtr:title><gtr:parentPublicationTitle>Trends in pharmacological sciences</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/9b2e047c2536b103fcf1a8b07b1eb073"><gtr:id>9b2e047c2536b103fcf1a8b07b1eb073</gtr:id><gtr:otherNames>Jarvis GE</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2013-01-01</gtr:date><gtr:issn>0165-6147</gtr:issn><gtr:outcomeId>pm_15248_28_23972927</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>3204C5EB-39CB-4BE2-8DD7-9B18ADCFE751</gtr:id><gtr:title>Cell-collagen interactions: the use of peptide Toolkits to investigate collagen-receptor interactions.</gtr:title><gtr:parentPublicationTitle>Biochemical Society transactions</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/3447db0c971ced8be12c6fb038ac4eeb"><gtr:id>3447db0c971ced8be12c6fb038ac4eeb</gtr:id><gtr:otherNames>Farndale RW</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2008-01-01</gtr:date><gtr:issn>0300-5127</gtr:issn><gtr:outcomeId>3E011E16857</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>D60A098F-DA87-402C-8548-A5C739A94383</gtr:id><gtr:title>Structural basis for the platelet-collagen interaction: the smallest motif within collagen that recognizes and activates platelet Glycoprotein VI contains two glycine-proline-hydroxyproline triplets.</gtr:title><gtr:parentPublicationTitle>The Journal of biological chemistry</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/55777bfb4bba6121876eb77f176533d8"><gtr:id>55777bfb4bba6121876eb77f176533d8</gtr:id><gtr:otherNames>Smethurst PA</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2007-01-01</gtr:date><gtr:issn>0021-9258</gtr:issn><gtr:outcomeId>C2CC756784D</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>E1D83151-AA74-4995-AA3C-BD1C98025557</gtr:id><gtr:title>Ginkgolide B and bilobalide block the pore of the 5-HT3receptor at a location that overlaps the picrotoxin binding site.</gtr:title><gtr:parentPublicationTitle>Neuropharmacology</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/0ea2b4141de2b0b21acbe1f462237306"><gtr:id>0ea2b4141de2b0b21acbe1f462237306</gtr:id><gtr:otherNames>Thompson AJ</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2011-01-01</gtr:date><gtr:issn>0028-3908</gtr:issn><gtr:outcomeId>g7ySZ8rffGa</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>88C0FD26-BB0F-4354-9516-C69FA10965BC</gtr:id><gtr:title>CD18-dependent activation of the neutrophil NADPH oxidase during phagocytosis of Escherichia coli or Staphylococcus aureus is regulated by class III but not class I or II PI3Ks.</gtr:title><gtr:parentPublicationTitle>Blood</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/b69f958d0a381f3030849518250d3521"><gtr:id>b69f958d0a381f3030849518250d3521</gtr:id><gtr:otherNames>Anderson KE</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2008-01-01</gtr:date><gtr:issn>0006-4971</gtr:issn><gtr:outcomeId>83F39E70970</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>6A211219-BF6C-4BD0-9479-0A66D14BCD09</gtr:id><gtr:title>Use of synthetic peptides to locate novel integrin alpha2beta1-binding motifs in human collagen III.</gtr:title><gtr:parentPublicationTitle>The Journal of biological chemistry</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/de7abef43ae9f408bc65ba23623514ab"><gtr:id>de7abef43ae9f408bc65ba23623514ab</gtr:id><gtr:otherNames>Raynal N</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2006-01-01</gtr:date><gtr:issn>0021-9258</gtr:issn><gtr:outcomeId>4C3F3C0FBB6</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>A7985FAA-6686-4770-9600-D886903630C1</gtr:id><gtr:title>PI3K? plays a critical role in neutrophil activation by immune complexes.</gtr:title><gtr:parentPublicationTitle>Science signaling</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/bf4791aaad3ff17c7499e3c358e997f1"><gtr:id>bf4791aaad3ff17c7499e3c358e997f1</gtr:id><gtr:otherNames>Kulkarni S</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2011-01-01</gtr:date><gtr:issn>1945-0877</gtr:issn><gtr:outcomeId>ivy5DorTeKm</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>2807A750-35F0-40EA-97FA-23D539D42C41</gtr:id><gtr:title>Identification of a major GpVI-binding locus in human type III collagen.</gtr:title><gtr:parentPublicationTitle>Blood</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/9b2e047c2536b103fcf1a8b07b1eb073"><gtr:id>9b2e047c2536b103fcf1a8b07b1eb073</gtr:id><gtr:otherNames>Jarvis GE</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2008-01-01</gtr:date><gtr:issn>0006-4971</gtr:issn><gtr:outcomeId>B5B93C903A1</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>49FC9CFD-C8EA-4530-88F4-1D2CE8FC2349</gtr:id><gtr:title>Platelet receptor recognition and cross-talk in collagen-induced activation of platelets.</gtr:title><gtr:parentPublicationTitle>Journal of thrombosis and haemostasis : JTH</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/3447db0c971ced8be12c6fb038ac4eeb"><gtr:id>3447db0c971ced8be12c6fb038ac4eeb</gtr:id><gtr:otherNames>Farndale RW</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2007-01-01</gtr:date><gtr:issn>1538-7836</gtr:issn><gtr:outcomeId>DE3C3FB1094</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>A21C2C6D-0B19-41B0-BEA4-EDD5BC0400E5</gtr:id><gtr:title>A role for adhesion and degranulation-promoting adapter protein in collagen-induced platelet activation mediated via integrin&amp;nbsp;a(2) ?(1).</gtr:title><gtr:parentPublicationTitle>Journal of thrombosis and haemostasis : JTH</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/9b2e047c2536b103fcf1a8b07b1eb073"><gtr:id>9b2e047c2536b103fcf1a8b07b1eb073</gtr:id><gtr:otherNames>Jarvis GE</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2012-01-01</gtr:date><gtr:issn>1538-7836</gtr:issn><gtr:outcomeId>fJcVvLNhC7i</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>1C0250E0-4076-4B68-A404-B12A7FB3665F</gtr:id><gtr:title>In vivo relevance for platelet glycoprotein Ibalpha residue Tyr276 in thrombus formation.</gtr:title><gtr:parentPublicationTitle>Journal of thrombosis and haemostasis : JTH</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/65afd042fee23340481ac03e0a4114af"><gtr:id>65afd042fee23340481ac03e0a4114af</gtr:id><gtr:otherNames>Guerrero JA</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2008-01-01</gtr:date><gtr:issn>1538-7836</gtr:issn><gtr:outcomeId>7A72818DD67</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>77128FA6-DABD-4059-B063-A9EB3B572641</gtr:id><gtr:title>The TRPV1 ion channel is expressed in human but not mouse platelets.</gtr:title><gtr:parentPublicationTitle>Platelets</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/063e116de0e31d97760ea4b63a8c2f9b"><gtr:id>063e116de0e31d97760ea4b63a8c2f9b</gtr:id><gtr:otherNames>Sage SO</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2014-01-01</gtr:date><gtr:issn>0953-7104</gtr:issn><gtr:outcomeId>56bc7fa3adbe68.52837893</gtr:outcomeId></gtr:publication></gtr:publications><gtr:identifiers><gtr:identifier type="RCUK">G0601378</gtr:identifier></gtr:identifiers><gtr:healthCategories><gtr:healthCategory><gtr:id>D4FDB752-4E9C-491F-9C63-B7D7F6F95417</gtr:id><gtr:percentage>100</gtr:percentage><gtr:text>Cardiovascular</gtr:text></gtr:healthCategory></gtr:healthCategories><gtr:researchActivities><gtr:researchActivity><gtr:id>1BF330A9-C7B5-49C5-B54B-CF4FAE6DF1D8</gtr:id><gtr:percentage>100</gtr:percentage><gtr:text>2.1  Biological and endogenous factors</gtr:text></gtr:researchActivity></gtr:researchActivities><gtr:researchSubjects/><gtr:researchTopics/><gtr:rcukProgrammes/></gtr:project></gtr:projectComposition></gtr:projectOverview>